ClinicalTrials.Veeva

Menu

GLUtEus Maximus Fascia Plasty Flap for Pilonidal Sinus (GLUE)

R

Russian Society of Colorectal Surgeons

Status

Enrolling

Conditions

Pilonidal Sinus

Treatments

Procedure: Gluteus Maximus Fascia Plasty Flap
Procedure: Primary Closure

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Surgical treatment is still gold standard for pilonidal sinus disease. Several surgical techniques have been proposed to treat this disease in the last two decades. A new method - midline excision of pilonidal sinus and wound closure using gluteus maximus fascia plasty flap (GMFF) - was proposed recently as a new method of treatment that results in low reccurence rate and good cosmetic results.

The aim of this study is to compare a new method (GMFF) with a traditional method (midline excision and primary closure) in terms of recurrence rate, complications and patient satisfaction with results.

Full description

Pilonidal sinus disease (PSD) is a rather rare benign condition (about 26 cases per 100,000 population) that affects primarily young adults. Because of purulent nature it is treated with surgery only.

Traditional surgical techniques encompass midline excision of the purulent cyst and either leaving the wound "lay open" for secondary closure or midline primary closure. The latter method has a major drawback of high recurrence rate and very long healing and patient disability periods. Therefore alternative techniques to close the wound after pilonidal sinus excision were proposed. In some a muscular-cutaneous flaps are created and the wound is closed in a Z- or Y- or other shape manner. The recurrence rate of these techniques is significantly lower than with a traditional midline closure, but healing time and final cosmetic results are far from ideal in patient view.

Recently a new method of wound closure was developed independently by a few groups that includes bilateral mobilisation of gluteus maximus muscles fascia and midline closure of the wound. Preliminary results demonstrated that this method leads to lower recurrence rate and better cosmetic results because the natal cleft is saved.

Enrollment

84 estimated patients

Sex

All

Ages

16 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Written informed consent
  2. Chronic primary or recurrent pilonidal sinus at the remission stage.
  3. Presence or absence of secondary orifices.
  4. Planned surgical treatment with excision of pilonidal sinus.
  5. Location of secondary orifices less than 2 cm from the natal cleft.
  6. The distance between bilateral symmetrical secondary orifices less than 2 cm.
  7. American Society Anesthesiologists (ASA) score 1 to 3

Non-inclusion Criteria:

  1. Acute pilonidal sinus abscess.
  2. The secondary openings (orifice) position more than 2 cm from the midline.
  3. ASA 4-5.
  4. Predictable impossibility of following the protocol.
  5. Pregnancy

Exclusion criteria

1 The patients lost for the further observation. 2. The patient's refusal to continue participate in the investigation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

84 participants in 2 patient groups

Primary Closure
Active Comparator group
Description:
After pilonidal sinus is excised, subcutaneous fat and skin are closed in midline with a running suture
Treatment:
Procedure: Primary Closure
Gluteus Maximus Plasty Flap
Active Comparator group
Description:
After pilonidal sinus is excised, gluteus maximus fascia flaps will be mobilised, approximated in the midline and fixed with a running suture. Subcutaneous fat and skin are closed in midline with a running suture.
Treatment:
Procedure: Gluteus Maximus Fascia Plasty Flap

Trial contacts and locations

1

Loading...

Central trial contact

Arcangelo Picciariello, MD; Darya Shlyk, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems